1. < Cedars Sinai DoM

ctDNA-guided adjuvant immunotherapy in colorectal cancer

By sjmartinez • November 18, 2024

Burley N, Lee Y, Liu L, Gangi A, Nasseri Y, Atkins K, Zaghiyan K, Murrell Z, Osipov A, Hendifar A, Hitchins M, Gong J. ctDNA-guided adjuvant immunotherapy in colorectal cancer. Immunotherapy. 2024 Nov 17:1-6. doi: 10.1080/1750743X.2024.2430941. Epub ahead of print. PMID: 39552190.

Tags: adjuvant therapy, Cedars Sinai DoM, colorectal cancer, ctDNA, Fellow, Hematology/Oncology, immunotherapy, microsatellite instability, mismatch repair deficient, Olive View DoM, Publications

Related Posts

Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trials

Gresham G, Henry NL, Bandos H, Calsavara VF, Cecchini RS, Diniz MA, Hays RD, Luu M, Kim S, Rogatko A, Yothers G, Ganz PA, Tighiouart[...]

What a pain in the back: etiology, diagnosis and future treatment directions for discogenic low back pain

Kaneda G, Zila L, Wechsler JT, Shafi K, Cheema K, Bae H, Kim SD, Tuchman A, Li D, Sheyn D. What a pain in the[...]

Oxidative stress-regulatory role of miR-10b-5p in the diabetic human cornea revealed through integrated multi-omics analysis

Zha D, Gamez J, Ebrahimi SM, Wang Y, Verma N, Poe AJ, White S, Shah R, Kramerov AA, Sawant OB, Santiskulvong C, Stotland AB, Wang[...]